Submit Deal

Aaron Pomeroy

Partner at Cooley

Lawyer

Colorado

Deal Bio

Total Deals22

Valued Deals17

Total Value£18,808M

Avg. Deal Size£1,106M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (22)

Sort

United States

Biotechnology

AcquisitionMajorityPrivateCross BorderPrivate Equity

target

FORBIUS

bidder

Bristol Myers Squibb Company

value n/a

49 dealmakers

United States

Biotechnology

MajorityPublicAcquisitionCross Border

target

Viela Bio

bidder

Horizon Therapeutics

£2,262m

42 dealmakers

United Kingdom

Information / Data Services

Cross BorderPrivateMajorityPrivate EquityAcquisition

target

BRANDWATCH

bidder

CISION

£322m

26 dealmakers

United Kingdom

Casinos and Gambling

Reverse TakeoverCross BorderDe-SPACMergerMajorityPrivateAcquisition

target

Super Group

bidder

Sports Entertainment Acquisition Corp.

£3,421m

63 dealmakers

Indonesia

FinTech

De-SPACMajorityPrivate EquityAcquisitionPrivateCross BorderReverse Takeover

target

Kredivo Holdings (ex Finaccel)

bidder

Palantir Technologies

£1,798m

85 dealmakers

Russian Federation

Mobility

PrivateDomesticAcquisitionMajority

target

Yandex Self Driving Group

bidder

Nebius Group (ex-yandex Nv)

£726m

24 dealmakers

Singapore

Software

MergerAcquisitionReverse TakeoverMajorityPrivateCross BorderDe-SPAC

target

BITDEER

bidder

Blue Safari Group Acquisition

£2,972m

12 dealmakers

Spain

Digital Services

Cross BorderAcquisitionMajorityPrivate

target

Busuu

bidder

Chegg

£326m

42 dealmakers

Iceland

Pharmaceuticals

Reverse TakeoverDe-SPACMergerMajorityPrivateAcquisitionPrivate EquityCross Border

target

ALVOTECH

bidder

Oaktree Acquisition Corp Ii

£1,697m

65 dealmakers

United States

Online and Social Platforms

MajorityAcquisitionReverse TakeoverPrivateDomesticDe-SPACMergerPrivate Equity

target

Grindr

bidder

Tiga Acquisition

£1,704m

52 dealmakers

United Kingdom

Biotechnology

MajorityCross BorderPrivateAcquisitionPrivate Equity

target

MIROBIO

bidder

Gilead Sciences

£333m

42 dealmakers

United States

Pharmaceuticals

AcquisitionMajorityPrivateDomestic

target

Hbt Labs

bidder

American Regent

value n/a

27 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy